270 related articles for article (PubMed ID: 29846905)
1. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
Shankar A; Crouch DH; Macluskey M
Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
[TBL] [Abstract][Full Text] [Related]
2. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
[TBL] [Abstract][Full Text] [Related]
4. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV.
Paver EC; Currie AM; Gupta R; Dahlstrom JE
Pathology; 2020 Feb; 52(2):179-191. PubMed ID: 31889547
[TBL] [Abstract][Full Text] [Related]
6. Infiltrates of M2-Like Tumour-Associated Macrophages Are Adverse Prognostic Factor in Patients with Human Papillomavirus-Negative but Not in Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Snietura M; Brewczynski A; Kopec A; Rutkowski T
Pathobiology; 2020; 87(2):75-86. PubMed ID: 32036360
[TBL] [Abstract][Full Text] [Related]
7. Reduced EBP50 expression or mis-localization of the EBP50 protein is associated with the malignant progression of esophageal squamous cell carcinoma.
Wang L; Du YR; Ji MY; Wang W; Zhan N; Zhou QS; Dong WG
Eur Rev Med Pharmacol Sci; 2014; 18(24):3854-63. PubMed ID: 25555876
[TBL] [Abstract][Full Text] [Related]
8. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas.
Salazar C; Calvopiña D; Punyadeera C
Expert Rev Mol Diagn; 2014 Nov; 14(8):1033-40. PubMed ID: 25222489
[TBL] [Abstract][Full Text] [Related]
9. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?
Thomas J; Primeaux T
Ann Diagn Pathol; 2012 Apr; 16(2):91-9. PubMed ID: 22197546
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 Expression in High-Risk HPV-Positive and Negative Head & Neck Squamous Cell Carcinomas and Regional Lymph Node Metastases.
Coppock JD; Mills AM; Stelow EB
Head Neck Pathol; 2021 Mar; 15(1):163-168. PubMed ID: 32564273
[TBL] [Abstract][Full Text] [Related]
11. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
12. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.
Bhosale PG; Pandey M; Desai RS; Patil A; Kane S; Prabhash K; Mahimkar MB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Nov; 122(5):609-618.e7. PubMed ID: 27765330
[TBL] [Abstract][Full Text] [Related]
14. Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.
Cohen N; Gupta M; Doerwald-Munoz L; Jang D; Young JE; Archibald S; Jackson B; Lee J; Chernesky M
J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):11. PubMed ID: 28193254
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 7 in Oropharyngeal Squamous Cell Carcinoma: A Junctional Biomarker for Human Papillomavirus-Related Tumors.
Woods RSR; Keegan H; White C; Tewari P; Toner M; Kennedy S; O'Regan EM; Martin CM; Timon CVI; O'Leary JJ
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):702-710. PubMed ID: 28082347
[No Abstract] [Full Text] [Related]
16. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
18. Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.
Payabvash S; Chan A; Jabehdar Maralani P; Malhotra A
Neuroradiol J; 2019 Aug; 32(4):232-240. PubMed ID: 31084347
[TBL] [Abstract][Full Text] [Related]
19. A proportion of primary squamous cell carcinomas of the parotid gland harbour high-risk human papillomavirus.
Xu B; Wang L; Borsu L; Ghossein R; Katabi N; Ganly I; Dogan S
Histopathology; 2016 Dec; 69(6):921-929. PubMed ID: 27374168
[TBL] [Abstract][Full Text] [Related]
20. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]